This information sheet explains that the number of Hispanics with hepatitis C (2.6%) is higher than the number of people with hepatitis C in the general population (1.3%). It also states that hepatitis C disease progression has been shown to be faster in Hispanics than in non-Hispanic whites. The fact sheet describes treatment of hepatitis C, which has been found to be as effective in Hispanics as it is in other groups.

This information sheet explains hepatitis E virus (HEV), which is mainly transmitted via a fecal-oral route due to contaminated water supplies, but other sources of infection have been identified. The fact sheet discusses transmission, prevention, symptoms, risk factors, and prevalence in the United States.

This information sheet discusses the prevalence of hepatitis C (HCV) in the Native American population, which is believed to be higher than in the general population. It states that there have been very few research papers on Native Americans and hepatitis C and provides some basic statistics and discusses risk factors. It concludes more studies need to take place to understand the true prevalence in this population.

This information sheet focuses on tips for reading and understanding an abstract, which can be very challenging for most people. It states that there are usually seven pieces to an abstract, then breaks them down and gives hints on how to understand them. It includes a copy of an abstract to illustrate how to go through each section. The fact sheet is geared toward people with hepatitis.

This information sheet states that there are clear differences in terms of chronicity, disease progression, and treatment response rates among different ethnic and racial groups with regard to hepatitis C virus (HCV), with the African American population the most pronounced. It says that African Americans are more likely to have been exposed to HCV and are less likely to resolve acute HCV infection compared to other racial/ethnic groups. The fact sheet gives information about HCV, disease progression, and treatment.

This information sheet discusses what happens when 100 people are infected with hepatitis C virus (HCV). A chart demonstrates that out of 100 people with an initial HCV infection, 55-80 will develop chronic infection. Out of those, 10-20 people will develop serious liver disease, and out of those, 2-3 people will develop liver cancer.

This information sheet discusses the immune system and how it reacts against hepatitis C virus (HCV). It explains the importance of the liver in the immune system and that most people infected with HCV will develop chronic HCV. It lists things that can be done to keep the immune system healthy.

This information sheet discusses the liver and its importance to the body. It describes how the liver acts as a filter for everything that an individual eats, drinks, or breathes in and how some things, such as alcohol, street drugs, and smoke, cause liver damage. It also explains that the hepatitis C virus (HCV) can cause scarring to the liver and over a long period of time can cause the liver to not function properly. The information sheet provides tips to keep the liver healthy.

This information sheet discusses drug interactions, specifically drug interactions with medications for hepatitis C virus (HCV) infection, including interactions between drugs and herbal medications and drug-drug interactions. It also discusses food and drink interactions and overdosing.

This information sheet discusses hepatitis A virus (HAV). It explains how it is transmitted, its symptoms, and prevention, including getting the hepatitis A vaccination.